The effectiveness of bupivacaine on pain relief after unilateral knee arthroplasty

Phase 2

Recruiting

• Conditions: nilateral knee arthroplasty.; Unspecified complication of internal orthopedic prosthetic device, implant and graft, initial encounter; T84.9XXA

• Registration Number: IRCT20220731055587N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Patients with ASA I or II, who are candidate for unilateral knee arthroplasty
Age over 18 years
BMI less than 35

Exclusion Criteria

History of neuropathy
Having coagulation disorder
Drug abuse
Having local anesthetics allergies

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The rate of pain. Timepoint: 3, 6, 12 and 24 hours after intervention. Method of measurement: Visual analogue scale (VAS).;Muscle strength. Timepoint: 12 and 24 hours after intervention. Method of measurement: Maximum voluntary isometric contraction (MVIC).

Secondary Outcome Measures

Name	Time	Method
The rate of pain reliever consumption. Timepoint: 24 hours after intervention. Method of measurement: Type and amount of pain reliever consumed by the patient.